Laboratory Operations Sample Clauses

Laboratory Operations a. The contractor shall annually perform approximately 15,000 inorganic, organic and radionuclide analyses. This number of analyses includes analyses for blanks, calibrations, equipment checks and actual samples analyzed. The sample analyses shall be performed on approximately 2,000 intermediate to high level radioactive and/or hazardous samples received from multiple locations and entities on the Hanford site. Samples received into the hot cell may be 300 Rad/hr, with a significant part of that from gamma radiation. Those high rad samples are diluted so that they can be analyzed in a ventilation hood. See Attachment 1, Required Laboratory Processes and Analyses, for the specific required capabilities. ESTIMATED ARRA WORK TO BE PERFORMED (A001) The following estimated work shall be performed in accordance with the rules and regulations under the American Recovery and Reinvestment Act of 2009, Pub. L. 1115 (Recovery Act). ARRA PROJECTS TOTAL ESTIMATED NUMBER OF ARRA SAMPLES K East Reactor (M013) 50 Balance of Site (RL 40 ARRA) 180 PFP Demo (RL 11 ARRA) 296
AutoNDA by SimpleDocs
Laboratory Operations. H-16/Item 1 “Increase in Laboratory Area: During Phase III, laboratory area would increase by 7% and chemical usage would presumably increase by a similar percent—with no additional significant impact.” 5I-32 H-16/Item 2 “Increase in Production Area: Occupied area would increase during Phases II and III to four and one-half times the present level, and the quantity of chemicals in use would increase proportionately.” 5I-32 H-16/Item 3 “Use of Ammonia: In lieu of increased use of CFC’s, a new refrigeration system using ammonia is proposed. While CFC’s pose a cumulative risk to the environment through destruction of the ozone layer, in the event of a release, ammonia would pose a greater acute hazard to workers, emergency responders, and the public, and would also pose a hazard to the environment.” 5I-33 Bayer will implement an Emergency Preparedness Program. Same as above. Bayer will obtain a certified Risk Management Prevention Program for the Ammonia Refrigeration System. H-16/Item 4Release of Ammonia: A risk of releasing ammonia during delivery and operation would exist. Workers and emergency responders could be exposed to hazardous conditions, and the environment and the public could be exposed to a cloud of ammonia vapor.” 5I-34 Same as above. S O C I OE C O NOM I C S ENVIRONMENTAL IMPACTS—EMPLOYMENT H-17/Item 1 “Job Training: Of the 380 jobs created over the 30-year project period, an estimated 58% would require some college education and another 17% require completion of high school. Even with continuation of the First Source Employment agreement between the City and Bayer/Cutter, many applicants referred by the City would not be qualified for the new positions.” 5J-4 H-17/Item 2 “Construction Jobs: The approximately 200 temporary construction jobs would not necessarily be filled by Berkeley residents.” 5J-4 H-17/Item 3 “Construction Job Training: To fill the temporary construction jobs, some Berkeley residents would need training.” 5J-4 & 5J-5 Bayer will design and implement a Biotech Academy at Berkeley High School and a Biotech Career Institute at a local community college. Bayer has agreed that all recruitment for new and replacement construction employees will first be sought via the Construction section of the City’s First Source Employment Program, in accordance with union policy and procedures. Bayer will establish a goal of hiring one (1) out of every five (5) workers in the total construction work force from First Source throughout the li...
Laboratory Operations. Develop and oversee the implementation of strategies, policies, procedures and best practice initiatives to optimize performance and ensure the quality of the Corporation’s laboratory operations Conduct internal assessment of laboratory workflows, personnel training and processes as a basis for same Assure that policies and procedures are appropriately interpreted, understood and implemented by laboratory operations personnel Establish defined reporting metrics for measure the operating and quality performance of the Corporation’s laboratory operations Establish a culture of continuous operational improvement
Laboratory Operations. Consultant, together with the Laboratory Director, shall manage and oversee all of the Laboratory’s clinical and operational activities, including, without limit, ensuring that: (i) the Laboratory’s testing systems are appropriate and provide quality services in all aspects of test performance (i.e., pre-analytic, analytic, and post-analytic phases of testing); (ii) the Laboratory’s physical and environmental conditions are adequate and appropriate for the testing performed; (iii) the environment for personnel is safe from physical, chemical, and biological hazards and that biohazard and safety requirements are followed; (iv) a general supervisor for high complexity testing is available to provide day-to-day supervision of all testing personnel and reporting of test results while providing on-site supervision for specific minimally qualified testing personnel when performing such high complexity testing; (v) sufficient numbers of appropriately qualified Laboratory Personnel (defined below) are employed at the Laboratory; (vi) new assay procedures are reviewed, included in the appropriate procedure manual, and followed by Technical Personnel (defined below); (vii) all assays are appropriately performed in accordance with Consultant and Company’s procedures and a weekly testing schedule to be agreed upon by the Parties (which schedules shall be designed, to the extent practicable, to maximize the efficiency of the performance of the Test Services (as defined below)); and (viii) if requested by Company, all Laboratory Personnel’s responsibilities and duties are specified in written standard operating procedures. Consultant shall provide training of the Technical Personnel on all methods and procedures of all tests performed by the Laboratory, including, without limit, the EsoGuard assay (collectively, the “Test Services”), as well as provide ongoing support to the Laboratory Personnel, as needed. Consultant will periodically monitor quality and efficiency and conduct periodic reviews to make recommendations to Company relating to the Test Services.

Related to Laboratory Operations

  • Development Work The Support Standards do not include development work either (i) on software not licensed from CentralSquare or (ii) development work for enhancements or features that are outside the documented functionality of the Solutions, except such work as may be specifically purchased and outlined in Exhibit 1. CentralSquare retains all Intellectual Property Rights in development work performed and Customer may request consulting and development work from CentralSquare as a separate billable service.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Research Support opioid abatement research that may include, but is not limited to, the following:

  • Field The term “

  • Development Diligence Novartis shall dedicate commercially reasonable efforts, during each [**] month period, necessary to continue the advancement of Licensed Compounds and Licensed Products with respect to at least one Profile towards the next clinical Development milestone or approval milestone, as described in Sections 7.4.2 or 7.4.3, respectively. If Novartis (itself or through its Affiliates or sublicensees) fails to dedicate commercially reasonable efforts, during any [**] month period, necessary to continue the advancement of Licensed Compounds and Licensed Products with respect to at least one Profile towards such next milestone, then any dispute regarding Novartis’ failure of development diligence with respect to such Profile shall be resolved in accordance with Article 13.

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

  • Projects The Annexes attached hereto describe the specific projects and the policy reforms and other activities related thereto (each, a “Project”) that the Government will carry out, or cause to be carried out, in furtherance of this Compact to achieve the Objectives and the Compact Goal.

  • Commercialization Activities Within North America, the Parties will use Commercially Reasonable Efforts to Commercialize Licensed Products in the Field. In addition, within North America and subject to Section 2.7.6, the Parties will use Commercially Reasonable Efforts to conduct the Commercialization activities assigned to them pursuant to the Commercialization Plan/Budget, including the performance of detailing in accordance therewith. In conducting the Commercialization activities, the Parties will comply with all Applicable Laws, applicable industry professional standards and compliance policies of Celgene which have been previously furnished to Acceleron, as the same may be updated from time to time and provided to Acceleron. Neither Party shall make any claims or statements with respect to the Licensed Products that are not strictly consistent with the product labeling and the sales and marketing materials approved for use pursuant to the Commercialization Plan/Budget.

  • Engineering Forest Service completed survey and design for Specified Roads prior to timber sale advertisement, unless otherwise shown in A8 or Purchaser survey and design are specified in A7. On those roads for which Forest Service completes the design during the contract, the design quantities shall be used as the basis for revising estimated costs stated in the Schedule of Items and adjusting Timber Sale Account. Forest Service engineering shall be completed according to the schedule in A8. Should Forest Service be unable to perform the designated survey and design by the completion date or other agreed to time, upon written agreement, Purchaser shall assume responsibility for such work. In such event, Contracting Officer shall revise:

Time is Money Join Law Insider Premium to draft better contracts faster.